INTRAVENOUS (IV) AFLIBERCEPT VERSUS PLACEBO IN COMBINATION WITH IRINOTECAN/5-FU (FOLFIRI) FOR SECOND-LINE TREATMENT OF METASTATIC COLORECTAL CANCER (MCRC): RESULTS OF A MULTINATIONAL PHASE III TRIAL (EFC10262-VELOUR)

Van Cutsem, Eric; Tabernero, Josep; Lakomy, Radek; Prausova, Jana; Ruff, Paul; Van Hazel, Guy; Moiseyenko, Vladimir; Ferry, David; McKendrick, Joe; Tellier, Alexia; Castan, Remi; Allegra, Carmen

Annals of Oncology

INTRAVENOUS (IV) AFLIBERCEPT VERSUS PLACEBO IN COMBINATION WITH IRINOTECAN/5-FU (FOLFIRI) FOR SECOND-LINE TREATMENT OF METASTATIC COLORECTAL CANCER (MCRC): RESULTS OF A MULTINATIONAL PHASE III TRIAL (EFC10262-VELOUR)

Author:

Van Cutsem, Eric

Tabernero, Josep ; Lakomy, Radek ; Prausova, Jana ; Ruff, Paul ; Van Hazel, Guy ; Moiseyenko, Vladimir ; Ferry, David ; McKendrick, Joe ; Tellier, Alexia ; Castan, Remi ; Allegra, Carmen

Keywords:

Science & Technology, Life Sciences & Biomedicine, Oncology, 1112 Oncology and Carcinogenesis, Oncology & Carcinogenesis, 3202 Clinical sciences, 3211 Oncology and carcinogenesis

Annals of Oncology INTRAVENOUS (IV) AFLIBERCEPT VERSUS PLACEBO IN COMBINATION WITH IRINOTECAN/5-FU (FOLFIRI) FOR SECOND-LINE TREATMENT OF METASTATIC COLORECTAL CANCER (MCRC): RESULTS OF A MULTINATIONAL PHASE III TRIAL (EFC10262-VELOUR)

Author:

Keywords:

Annals of Oncology

INTRAVENOUS (IV) AFLIBERCEPT VERSUS PLACEBO IN COMBINATION WITH IRINOTECAN/5-FU (FOLFIRI) FOR SECOND-LINE TREATMENT OF METASTATIC COLORECTAL CANCER (MCRC): RESULTS OF A MULTINATIONAL PHASE III TRIAL (EFC10262-VELOUR)